<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Omar Naseem Alzrigat</style></author><author><style face="normal" font="default" size="100%">Yazeed Nabeel Al-Qusous</style></author><author><style face="normal" font="default" size="100%">Dema Maher Masadeh</style></author><author><style face="normal" font="default" size="100%">Madleen Nabeel Al-Qusous</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Discover How Ashwagandha May Impact Health: A Comprehensive Review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-inflammatory</style></keyword><keyword><style  face="normal" font="default" size="100%">Anticancer dosage</style></keyword><keyword><style  face="normal" font="default" size="100%">Antioxidant</style></keyword><keyword><style  face="normal" font="default" size="100%">Ashwagandha</style></keyword><keyword><style  face="normal" font="default" size="100%">Toxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Withania somnifera</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">394-398</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Withania somnifera (Ashwagandha) is a medicinal herb that has been commonly utilized in traditional medicine for millennia, particularly in Ayurvedic practices. The root of the plant is pharmacologically active and has been used for its aphrodisiac, diuretic, anti-helminthic, narcotic, tonic, and stimulant properties. Additionally, other parts of ashwagandha, including the leaves, shoots, seeds, and berries, contribute to its health-promoting effects and the potential for improving longevity. This plant is composed of many bioactive compounds which exhibit a myriad of health-enhancing properties. Contemporary research has focused on the multifaceted bioactivities of ashwagandha, revealing promising impacts such as anticancer, antioxidant, and anti-inflammatory activities, among other therapeutic applications. This review was planned to find the most recent findings, providing an examination of the active constituents of ashwagandha, their biological activities, and a critical assessment of any associated safety concerns and potential toxicity.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">394</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Omar Naseem Alzrigat&lt;sup&gt;1&lt;/sup&gt;, Yazeed Nabeel Al-Qusous&lt;sup&gt;2&lt;/sup&gt;, Dema Maher Masadeh&lt;sup&gt;1&lt;/sup&gt;, Madleen Nabeel Al- Qusous&lt;sup&gt;3*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;King Hussein Medical Center, Amman 11855, JORDAN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, Mutah University, Al-Karak 61710, JORDAN.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Clinical Pharmacy, Faculty of Pharmacy, Mutah University, Al-Karak 61710, JORDAN.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ashwani Kumar</style></author><author><style face="normal" font="default" size="100%">Prikshat Kumar Angra</style></author><author><style face="normal" font="default" size="100%">Suresh Chandra Akula</style></author><author><style face="normal" font="default" size="100%">Pritpal Singh</style></author><author><style face="normal" font="default" size="100%">Anuj Sharma</style></author><author><style face="normal" font="default" size="100%">Anup Sharma</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Efficacy of Standardized Withania Somnifera as Neuro Agent in Tension-Type Headache: A Comparative Trial of Data in Transit</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Biomarker Integrity</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemical Standardization</style></keyword><keyword><style  face="normal" font="default" size="100%">Sustainable Research Framework</style></keyword><keyword><style  face="normal" font="default" size="100%">Tension-Type Headache</style></keyword><keyword><style  face="normal" font="default" size="100%">Withania somnifera</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">378-385</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; To evaluate the role of withania somnifera as a neuro-psychiatric agent in the treatment of Tension-Type Headache (TTH), there is a need to substantiate the therapy using solid therapeutic evidence. Although using traditional medicine has a great potential, it is difficult to demonstrate the efficacy of a particular phytochemical composition regarding the frequency of and physiological stress markers of the chronic Tension-Type Headache in standardized research. &lt;strong&gt;Objective: &lt;/strong&gt;The purpose of the study is to assess the therapeutic efficacy of a standardized Withania somnifera extract in reducing the frequency of and physiological stress markers of the chronic Tension-Type Headache. Methods: We used the study as a double-blind and randomized controlled trial (RCT). The subjects were randomly selected to be given a standardized extract of the root of W. somnifera, that has been titrated to contain 5 percent withanolides, or a placebo dose of 60 days. The paper ensured a rigorous &quot;molecular chain of custody&quot; with a batch of withanolides linked in clinical outcome reported where the mean frequency of headaches in the treatment group reduced by 42% (p [Less than] 0.005). &lt;strong&gt;Results:&lt;/strong&gt; Clinical outcome showed that there was a significant decline in the frequency of headaches in the treatment group by 42% (p [Less than] 0.005). Moreover, the Ashwagandha group was showing a significant drop in salivary cortisol levels, which means that there was a decrease in the level of physiological stress response to chronic TTH. &lt;strong&gt;Conclusion:&lt;/strong&gt; Standardized natural products should be integrated into clinical trials as it is the most beneficial to the development of sustainable pharmacognosy. This experiment can offer an unambiguous evidence base, a clear and reproducible basis of evidence regarding the use of Ashwagandha in the current neurological practice by showing the clear efficacy in reducing the frequency of Tension-Type Headaches and biological stress markers.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">378</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ashwani Kumar&lt;sup&gt;2*&lt;/sup&gt;, Prikshat Kumar Angra&lt;sup&gt;2&lt;/sup&gt;, Suresh Chandra Akula&lt;sup&gt;1&lt;/sup&gt;, Pritpal Singh&lt;sup&gt;1&lt;/sup&gt;, Anuj Sharma&lt;sup&gt;2&lt;/sup&gt;, Anup Sharma&lt;sup&gt;1&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Mittal School of Business, Lovely Professional University, Phagwara, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;School of Computer Applications, Lovely Professional University, Phagwara, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nitin Govindrao Dumore</style></author><author><style face="normal" font="default" size="100%">Milind Janrao Umekar</style></author><author><style face="normal" font="default" size="100%">Brijesh Gulabrao Taksande</style></author><author><style face="normal" font="default" size="100%">Manish Manohar Aglawe</style></author><author><style face="normal" font="default" size="100%">Nandkishor Ramdasji Kotagale</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effects of Withania somnifera Nicotine Induced Conditioned Place Preference in Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Condition place preference</style></keyword><keyword><style  face="normal" font="default" size="100%">Nicotine</style></keyword><keyword><style  face="normal" font="default" size="100%">Withania somnifera</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">43-47</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Herbal medicines can be novel treatment strategies for management of nicotine addiction. Withania somnifera (Ashwagandha) is an Indian medicinal plant of great medicinal value; used in many clinically proven conditions. Objective: In present study we aimed at investigating the effect of withania somnifera extract (WSE) on preventing nicotine mediated effects attributed for the development of addiction. &lt;strong&gt;Material and Methods:&lt;/strong&gt; Mice were treated with nicotine and/or WSE and subjected to nicotine induced conditioned place preference (CPP) in male albino mice was checked.&lt;strong&gt; Results: &lt;/strong&gt;Application of two-way ANOVA showed that with preconditioning and post-conditioning values as a within-subjects (column) factor and treatment as an independent between subject (row) factor. Two-way ANOVA revealed significant effect of treatment [F(3,40)=4.119, p&amp;lt;0.05], time [F(1,40)=23.76, p&amp;lt;0.001] and interactiontreatment x time [F(3,40)=5.244, p&amp;lt;0.01] on Intra-peritoneal (ip) administration of nicotine (1 mg/kg). WSE did not produce any changes in the preference to drug-paired compartment. Factors like treatment [F(3,40) = 0.656, p&amp;gt;0.05], time [F(1,40) = 7.383, p&amp;lt;0.01] and interactiontreatment x time [F(3,40) = 0.5748, p&amp;gt;0.05] showed insignificant effects. Withania somnifera (50,100,200 mg/kg ip) coadministered with nicotine during the 6 days conditioning sessions completely abolished the acquisition of nicotine-induced CPP in mice. &lt;strong&gt;Conclusion:&lt;/strong&gt; Above data indicate that withania somnifera attenuate nicotine induced CPP. Hence it has potential as an anti-addictive therapy.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">43</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Nitin Govindrao Dumore&lt;sup&gt;1,2*&lt;/sup&gt;, Milind Janrao Umekar&lt;sup&gt;1&lt;/sup&gt;, Brijesh GulabraoTaksande&lt;sup&gt;1&lt;/sup&gt;, Manish Manohar Aglawe&lt;sup&gt;1&lt;/sup&gt;, Nandkishor Ramdasji Kotagale&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Division of Neuroscience, Department of Pharmacology, Smt.kishoritai Bhoyar College of pharmacy Kamptee, Nagpur 441002 Maharashtra, INDIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Dadasaheb Balpande College of Pharmacy, Besa, Nagpur,440037 Maharashtra, INDIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmacognosy, Government college of Pharmacy, Amaravati, 444601, Maharashtra, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>